Paratek Pharmaceuticals
Paratek Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, focused on developing and commercializing innovative treatment options to address significant medical challenges, particularly in the realm of antimicrobial resistance (AMR). Their flagship product, NUZYRA, is an FDA-approved antibiotic aimed at treating community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
The company is committed to combating AMR, a pressing global public health issue that claims the lives of approximately 160,000 Americans annually. Paratek's dedicated team works towards creating solutions that not only enhance patient outcomes but also promote responsible antibiotic use and advance research into new treatment technologies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

